Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Treace Medical Concepts (TMCI) Cost of Revenue (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Cost of Revenue readings, the most recent being $110.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 198.6% to $110.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $164.3 million, a 39.92% increase, with the full-year FY2025 number at $140.9 million, down 4.58% from a year prior.
  • Cost of Revenue hit $110.1 million in Q4 2025 for Treace Medical Concepts, up from $10.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $110.1 million in Q4 2025 to a low of -$65.8 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $21.3 million (2021), compared with a mean of $22.5 million.
  • Biggest five-year swings in Cost of Revenue: surged 794.5% in 2021 and later tumbled 829.29% in 2023.
  • Treace Medical Concepts' Cost of Revenue stood at $53.9 million in 2021, then crashed by 83.26% to $9.0 million in 2022, then tumbled by 829.29% to -$65.8 million in 2023, then skyrocketed by 156.03% to $36.9 million in 2024, then skyrocketed by 198.6% to $110.1 million in 2025.
  • The last three reported values for Cost of Revenue were $110.1 million (Q4 2025), $10.5 million (Q3 2025), and $33.1 million (Q2 2025) per Business Quant data.